Predictions
J.B. Hunt Transport Services Inc.
Start price
Target price
Perf. (%)
€164.00
17.10.21
17.10.21
-
17.10.22
17.10.22
5.85%
15.09.22
15.09.22
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Capable Management
Top 10 in its market
J.B. Hunt Transport Services Inc.
Start price
Target price
Perf. (%)
€164.00
17.10.21
17.10.21
-
17.10.22
17.10.22
5.85%
15.09.22
15.09.22
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Capable Management
Top 10 in its market
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€19.80
17.10.21
17.10.21
€25.00
17.10.22
17.10.22
-15.53%
26.11.21
26.11.21
Could be worthwhile Investment >10% per year
Concert Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.44
17.10.21
17.10.21
-
17.10.22
17.10.22
121.23%
28.05.22
28.05.22
Could be worthwhile Investment >10% per year
Durect Corp.
Start price
Target price
Perf. (%)
€1.03
17.10.21
17.10.21
-
17.10.22
17.10.22
-48.06%
18.10.22
18.10.22
Probably not worthwhile Investment
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€180.85
16.10.21
16.10.21
€160.00
16.10.22
16.10.22
-6.22%
24.10.21
24.10.21
Could be worthwhile Investment >10% per year
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€9.36
16.10.21
16.10.21
€20.00
16.10.22
16.10.22
47.44%
17.10.22
17.10.22
Could be worthwhile Investment >10% per year
Regulus Therapeutics Inc.
Start price
Target price
Perf. (%)
€4.44
16.10.21
16.10.21
€8.00
16.10.22
16.10.22
-62.16%
17.10.22
17.10.22
Could be worthwhile Investment >10% per year
Carisma Therapeutics Inc.
Start price
Target price
Perf. (%)
€16.58
16.10.21
16.10.21
-
16.10.22
16.10.22
22.56%
24.10.21
24.10.21
Could be worthwhile Investment >10% per year
Carisma Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.07
16.10.21
16.10.21
-
16.10.22
16.10.22
-
16.10.21
16.10.21
Could be worthwhile Investment >10% per year
Carisma Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.07
16.10.21
16.10.21
-
16.10.22
16.10.22
-
16.10.21
16.10.21
Could be worthwhile Investment >10% per year
Carisma Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.07
16.10.21
16.10.21
-
16.10.22
16.10.22
-
16.10.21
16.10.21
Could be worthwhile Investment >10% per year
Freeport-McMoRan Inc.
Start price
Target price
Perf. (%)
€33.83
16.10.21
16.10.21
€30.00
16.10.22
16.10.22
-15.81%
17.10.22
17.10.22
Could be worthwhile Investment >10% per year
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€39.35
15.10.21
15.10.21
-
18.01.25
18.01.25
-50.90%
24.01.22
24.01.22
Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€23.62
15.10.21
15.10.21
-
18.01.25
18.01.25
-45.89%
24.01.22
24.01.22
Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Kulicke & Soffa Industries Inc.
Start price
Target price
Perf. (%)
€44.20
15.10.21
15.10.21
€60.00
21.10.22
21.10.22
-3.56%
16.06.22
16.06.22
Could be very worthwhile Investment >20% year
Undervalued
Capable Management
Significant cyclical dependencies
Salesforce.com
Start price
Target price
Perf. (%)
€244.80
13.10.21
13.10.21
€255.00
13.10.22
13.10.22
6.19%
30.10.21
30.10.21
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
Future proof or reliable business model
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€30.25
13.10.21
13.10.21
€34.00
30.07.22
30.07.22
-32.13%
14.03.22
14.03.22
Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€470.00
13.10.21
13.10.21
-
13.10.22
13.10.22
24.89%
13.03.22
13.03.22
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€470.00
13.10.21
13.10.21
-
13.10.22
13.10.22
24.89%
13.03.22
13.03.22